BeyondSpring Inc. (NASDAQ: BYSI)
$2.31
+0.0600 ( +2.67% ) 31.6K
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.
Market Data
Open
$2.31
Previous close
$2.25
Volume
31.6K
Market cap
$93.09M
Day range
$2.24 - $2.32
52 week range
$0.65 - $4.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 5 | Jun 12, 2024 |
| 20-f | Annual reports | 26 | Apr 29, 2024 |
| 6-k | Quarterly Reports | 1 | Mar 18, 2024 |
| 6-k | Quarterly Reports | 2 | Feb 26, 2024 |
| 6-k | Quarterly Reports | 19 | Feb 02, 2024 |
| 6-k | Quarterly Reports | 1 | Jan 16, 2024 |
| 6-k | Quarterly Reports | 2 | Jan 10, 2024 |
| 6-k | Quarterly Reports | 2 | Dec 18, 2023 |
| 6-k | Quarterly Reports | 2 | Oct 30, 2023 |
| 6-k | Quarterly Reports | 2 | Oct 04, 2023 |